APA

Ruan J. J., Yu Y., Hou W., Chen Z., Fang J., Zhang J., Ni M., Li D., Lu S., Rui J., Wu R., Zhang W. & Ruan B. H. (2019). Kidney-Type Glutaminase Inhibitor Hexylselen Selectively Kills Cancer Cells via a Three-Pronged Mechanism. : ACS pharmacology & translational science.

Chicago

Ruan Jennifer Jin, Yu Yan, Hou Wei, Chen Zhao, Fang Jinzhang, Zhang Jingjing, Ni Muowei, Li Di, Lu Shiying, Rui Jingjing, Wu Rui, Zhang Wei and Ruan Benfang Helen. 2019. Kidney-Type Glutaminase Inhibitor Hexylselen Selectively Kills Cancer Cells via a Three-Pronged Mechanism. : ACS pharmacology & translational science.

Harvard

Ruan J. J., Yu Y., Hou W., Chen Z., Fang J., Zhang J., Ni M., Li D., Lu S., Rui J., Wu R., Zhang W. and Ruan B. H. (2019). Kidney-Type Glutaminase Inhibitor Hexylselen Selectively Kills Cancer Cells via a Three-Pronged Mechanism. : ACS pharmacology & translational science.

MLA

Ruan Jennifer Jin, Yu Yan, Hou Wei, Chen Zhao, Fang Jinzhang, Zhang Jingjing, Ni Muowei, Li Di, Lu Shiying, Rui Jingjing, Wu Rui, Zhang Wei and Ruan Benfang Helen. Kidney-Type Glutaminase Inhibitor Hexylselen Selectively Kills Cancer Cells via a Three-Pronged Mechanism. : ACS pharmacology & translational science. 2019.